| abstract |
pharmaceutical compositions based on lopap and uses of said compositions the invention relates to pharmaceutical compositions comprising: (a) a prophylactically or therapeutically effective amount of at least one polypeptide substantially identical to lopap (a lipocalin with prothrombin activating protease activity), including the recombinant form, and (b) a pharmaceutically acceptable carrier. the invention also relates to cosmetic compositions based on lopap, including the recombinant form, the invention relates, in particular, to the uses of said compositions as programmed cell death modulators (anti-apoptotic), vasodilators by raising nitric oxide and as antiaging agents. |